Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$19,102,296
+$965,812 QoQ
Shares Held
148,656
-1.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.47%
of 13F equity value
Holder Rank
#532
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stonebridge Capital Advisors LLC holds $79,452,749 across 7 Drug Manufacturers - General names. MRK ranks #2 (24.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
86,589 | $21,991,008 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
148,656 | $19,102,296 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
112,875 | $14,260,627 | |
| 4 | LLY |
ELI LILLY & Co
|
11,574 | $13,882,203 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
162,082 | $9,339,164 | |
| 6 | PFE |
Pfizer Inc
|
20,095 | $483,887 | |
| 7 | ABBV |
AbbVie Inc.
|
1,564 | $393,564 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,102,296 | 148,656 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $18,136,484 | 150,773 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $16,289,406 | 154,754 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,836,841 | 152,947 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $12,117,575 | 153,077 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $13,887,128 | 154,714 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $14,637,885 | 147,144 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,394,316 | 144,367 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,930,269 | 136,755 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $17,618,095 | 133,521 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $13,988,247 | 128,309 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,749,842 | 123,845 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $14,071,118 | 121,944 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $13,393,756 | 125,893 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $14,055,700 | 126,685 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $11,005,016 | 127,787 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,602,476 | 127,262 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $10,491,979 | 127,873 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,373,685 | 122,308 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,072,461 | 120,789 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,218,111 | 105,672 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,146,258 | 105,672 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,780,403 | 95,115 | Shares | Sole | 2021-03-05 | |
| 2020-09-30 | $7,529,623 | 90,773 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $6,848,115 | 88,557 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,718,090 | 87,316 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||